Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosfered is an Italian biotechnology company that specializes in the identification and production of high-titer bioactive compounds derived from plant sources. As a spin-off from the University of Turin, the company utilizes advanced analytical chemistry and extraction techniques to develop standardized ingredients for the nutraceutical, cosmetic, and food industries. Their product portfolio includes proprietary extracts such as Oxi-fend, Olygoplus, and others focused on antioxidant and anti-inflammatory properties. Biosfered emphasizes scientific validation and rigorous quality control to ensure the efficacy and safety of its natural active ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on cBiosfered.